Left Menu
Development News Edition

Takeda-led COVID-19 plasma treatment enters clinical trial with first patient

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months of regulatory delays.

Reuters | Tokyo | Updated: 09-10-2020 06:19 IST | Created: 09-10-2020 06:19 IST
Takeda-led COVID-19 plasma treatment enters clinical trial with first patient

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months of regulatory delays. The phase 3 trial by the group, known as the CoVIg Plasma Alliance, aims to enroll 500 adult patients from the United States, Mexico and 16 other countries, according to a statement.

Patients will be treated with Gilead Science Inc's Remdesivir alongside the plasma treatment, which will be provided by CSL Behring, Takeda and two other companies. "We are hopeful that data from the clinical trial will be available before the end of the year," Bill Mezzanotte, chief medical officer of CSL Behring, said in the release.

The group had aimed to begin the clinical trial in July, but it was delayed pending regulatory approval. The National Institutes of Health in the U.S. is the trial's sponsor. The alliance, which also includes Germany's Biotest AG and Octapharma Plasma, is working on a hyperimmune globulin therapy derived from the blood plasma of people who have recovered from COVID-19.

It offers a standardised dose of antibodies and doesn't need to be limited to patients with matching blood types.

Also Read: Trump doing well, undergoing Remdesivir therapy: WH doctor


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Videos

Latest News

Britain gets ready for roll-out of Pfizer's COVID-19 vaccine this week

Britain is preparing to become the first country to roll out the PfizerBioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to doctors clinics, the government said on Sunday. The f...

Rugby-'A work in progress', Rennie reflects on Australia's almost season

But for three errant Reece Hodge kicks, coach Dave Rennie would have been contemplating a very different first season in charge of Australia on Saturday night.If Hodge had converted late penalties in a draw against New Zealand and two again...

Cricket-NZ wrap up record win over West Indies in first test

New Zealand wrapped up a record innings and 134-run victory over West Indies before lunch on the fourth day of the first test in Hamilton on Sunday after finally breaking a rearguard action from Jermaine Blackwood and Alzarri Joseph.The vic...

Reuters US Domestic News Summary

Following is a summary of current US domestic news briefs. Kia recalls 295,000 U.S. vehicles for fire risksKia Motors Corp said on Saturday it is recalling 295,000 U.S. vehicles for engine fire risks. The Korean automaker said the recall co...

Give Feedback